- KWS will be at Booth 311 at ECCMID 2013... more
- KWS is now ISO 9001 accredited... more
- KWS will attend BIO-Europe Spring 2013... more
- KWS BioTest will be attending Superbugs and Superdrugs 2013... more
- KWS BioTest has a new CEO... more
- KWS BioTest will be attending BIO-Europe 2012... more
- BOS Non-clinical 2012 conference ... more
- ICAAC 2012 conference ... more
- EPIC Biotech 2012... more
- BioTrinity 2012 conference ... more
- MEDILINK Awards 2012... more
- BIA Research and Development Conference... more
Shaping Tomorrow's Solutions
A Preclinical CRO, Preclincial Contract Research Organisation, providing Efficacy Testing and Lead Compound Development
Welcome to KWS BioTest
KWS BioTest is a leading edge preclinical CRO, preclinical contract research organisation, which works closely with clients to develop lead compounds as novel treatments for human disease.
We provide efficacy models within the core areas of:
We work with clients to understand the unique attributes of each individual programme, to design appropriate research and development protocols and to develop a truly bespoke and individual service. In doing so, we draw from our extensive expertise and range of technical skills, and are continually developing and validating new services to meet the demands of the modern pharmaceutical industry.
Preclinical CRO, preclinical contract research organisation, KWS BioTest is the winner of the South West Biomedical iNet Innovation Award for Growth! KWS are also ISO 9001 accredited.
KWS BioTest – A Preclinical CRO, preclinical contract research organisation, providing efficacy testing and lead compound development.